Home EquiTrex®350

EquiTrex®350 10ml vial

Boldenone Undecylenate 350mg/mll, 10 mL Multidose Vial



Therapeutic Class:
Anabolic Agent


Each 1 ml of CYPIOTREX350 contains

350 mg Boldenone Undecylenate

Ethlyl Oleate q.s.

For Intramuscular Administration

Indication & Dosage:

Certain pathophysiological or catabolic processes in animals.
As anabolic after debilitating illness
The dosage for horses is 0.28 to 1.10 mg/kg (0.13-0.5 mg/lb) of body

weight intramuscularly. Treatment may be repeated every 2 to 3 weeks.

The condition should be assessed by a veterinarian to determine the

duration of treatment; however, most horses will respond with one or

two treatments.


In the absence of data on the effect of boldenone undecylenate on immature colts and

fillies, stallions, pregnant mares or brood mares during the breeding season, this drug

should not be used in these animals.
    Special Precautions          
For horses only. This drug is not to be administered to horses that are to be slaughtered
for use in food. Keep out of reach of children.

    Adverse Drug Reactions   
Treatment with EQUITREX injectable (boldenone undecylenate injection) may
result in androgenic effects (masculinization, behavioural effects) being expressed
in some animals. If these effects occur, they may persist for up to 6 to 8 weeks.
No additional injections of boldenone undecylenate should be administered.
    Drug Interactions               
May increase effects of oral anticoagulants, insulin,

oral antidiabetic agents, adrenal steroid, adrenocorticotropic hormone (ACTH).                                                                                                  

    Pregnancy Category
Category X: Studies in animals beings have demonstrated foetal

abnormalities or there is evidence of foetal risk.



Store at room temperature, between 59 and 86 degrees F (15 and 30 degrees C), in a tightly-closed container. Store away from heat, moisture, and light.

Do not store in the bathroom. Keep out of the reach of children and away from pets.

Concentrex Laboratiories N. V., Moerstraat 58, 9031, Gent, Belgium

Reg. No. Licence: 253/55-C9/2010/BE
Manufactured under WHO cGMP guidelines
Date of Preparation : 19 july 2010